drugset / Trial / NCT01266161
Multiple Dose Dental Pain Study Of Ibuprofen Extended Release
RandomizedParallel-groupTriple-blindTreatment
Summary
The study hypothesis is that single and multiple doses of ibuprofen 600 mg ER caplets provide analgesic efficacy superior to placebo over 12-hour dosing intervals.
Timeline
- Start
- 2010-11-22
- Primary completion
- 2011-03-31
- Completion
- 2011-03-31
Outcome
Met primary endpoint
registry MEAN Ibuprofen: 41.5 (Standard Deviation 21.0) units on a scale NCT01266161 ↗
registry analysis (superiority test); Placebo vs Ibuprofen; p <0.001; Mean Difference (Final Values) 23.76 (95% CI 16.45 to 31.07); ANOVA NCT01266161 ↗
registry MEAN Ibuprofen: 18.4 (Standard Deviation 12.1) units on a scale NCT01266161 ↗
registry analysis (superiority test); Placebo vs Ibuprofen; p <0.001; Mean Difference (Final Values) 8.42 (95% CI 4.13 to 12.71); ANOVA NCT01266161 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibuprofen | Small molecule | 600 mg | — |
Indications
No indication recorded.